
1801.HK-5.21%14.3%

2565.HK-89.21%14.3%

3933.HK-49.42%14.3%

AMGN+35.64%14.3%

LLY+39.84%14.3%

NVO-36.52%14.3%

ROG.SW+7.12%14.3%
As of Oct 2, 2026, 9:55 PM ET
GLP-1 Long '24: GLP1 Drug Producer Constituents
Amgen Inc.AMGN | 14.3% | -1.04% | -1.67% | -8.91% | -0.95% | 23.25% | 3.93% | 31.96% | 35.64% | 27.96% | 108.91% | $217.52B |
Eli Lilly and CompanyLLY | 14.3% | -0.74% | -2.02% | -1.17% | -0.29% | 6.68% | 8.98% | 40.12% | 39.84% | 29.27% | 414.47% | $1.08T |
Innovent Biologics, Inc.1801.HK | 14.3% | -1.84% | -6.69% | -5.50% | -1.84% | 25.19% | 12.78% | 91.49% | -5.21% | 107.48% | 26.43% | $21.35B |
Novo Nordisk A/SNVO | 14.3% | -0.21% | -5.36% | -20.27% | -0.29% | -26.71% | -0.43% | -45.35% | -36.52% | -67.57% | -19.11% | $165.72B |
PegBio Co., Ltd.2565.HK | 14.3% | 0.00% | 1.46% | 2.64% | 10.08% | -91.75% | -91.15% | -50.80% | -89.21% | -58.57% | -58.48% | $238.1M |
Roche Holding AGROG.SW | 14.3% | 0.00% | -1.25% | -2.19% | 0.00% | -7.80% | -20.04% | 17.32% | 7.12% | 29.07% | 18.22% | $304.61B |
The United Laboratories International Holdings Limited3933.HK | 14.3% | -4.39% | -4.67% | -9.27% | -4.39% | -34.58% | -41.51% | -45.24% | -49.42% | -24.65% | 78.47% | $1.91B |
| Theme return | — | -1.17% | -2.89% | -6.27% | 0.30% | -27.43% | -29.76% | 8.24% | -25.28% | 7.91% | 96.22% | — |
| Average | 14.3% | -1.17% | -2.89% | -6.38% | 0.33% | -15.10% | -18.21% | 5.64% | -13.97% | 6.14% | 81.27% | $255.38B |
| Median | 14.3% | -0.74% | -2.02% | -5.50% | -0.29% | -7.80% | -0.43% | 17.32% | -5.21% | 27.96% | 26.43% | $165.72B |
| Std Dev | 0.0% | 1.45% | 2.61% | 6.91% | 4.22% | 37.82% | 34.58% | 50.37% | 43.60% | 56.54% | 145.59% | $352.51B |
| Min | 14.3% | -4.39% | -6.69% | -20.27% | -4.39% | -91.75% | -91.15% | -50.80% | -89.21% | -67.57% | -58.48% | $238.1M |
| Max | 14.3% | 0.00% | 1.46% | 2.64% | 10.08% | 25.19% | 12.78% | 91.49% | 39.84% | 107.48% | 414.47% | $1.08T |
| % Positive Tickers | 0.00% | 14.29% | 14.29% | 14.29% | 42.86% | 42.86% | 57.14% | 42.86% | 57.14% | 71.43% |